Report from the 3rd International STI Workshop, 2002
Publication • 2002March 23-24, 2002 Montréal, Quebec, Canada Sponsored by: Foundation for AIDS & Immune Research The Forum for Collaborative HIV Research Gay Men’s Health Crisis Project Inform Treatment Action Group Linda Grinberg (1951–2002) · In Memoriam Linda Grinberg, a fearless AIDS treatment activist, founder and president of the Foundation for AIDS and Immune Research (FAIR) and…
Vaccine Advance: Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway
TAGline • 2001Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway “Still Could Fail” While a handful of companies are testing or have tested potential HIV vaccines in human volunteers, none of these trials have generated nearly as much excitement as the latest announcement from officials at Merck. After shifting its vaccine screening program into overdrive…
Vaccine Vitriol: Call for Poor Country Focus on Treatment, Care Programs Elicits Voice of Concern from Vaccine Outfit
TAGline • 2001Call for Poor Country Focus on Treatment, Care Programs Elicits Voice of Concern from Vaccine Outfit By Mark Harrington Price of Global Public Health HIV $4.06 billion TB $500 million Malaria $1.0 billion Add’l. infrastructure $440 million TOTAL, Yrs 1 – 3 $6.0 billion Add’l. rx and care $4.0 billion TOTAL, Yrs 5 –…
Simian Success: Vaccine Study Seen as Significant Advance, But Questions Remain About Human Applicability
TAGline • 2001Vaccine Study Seen as Significant Advance, But Questions Remain About Human Applicability By David Gold “The Whole Field Energized” Few monkey studies have attracted more attention than one recently published in Science (October 20, 2000). Conducted by Harvard researchers and funded by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), the study showed…
Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV
TAGline • 2001Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV Identifying “Resistance” Epitopes By Richard Jeffreys In the United States, long-term studies of HIV-infected and high-risk people have mainly involved gay men — the group most heavily affected in the epidemic’s early years. But a continent away, in the Pumwani district of…
African Epistle: Outrage, Indifference Greet Plans for Worldwide Treatment Agenda — As Millions More Die
TAGline • 2001Outrage, Indifference Greet Plans for Worldwide Treatment Agenda — As Millions More Die By Mark Harrington “No Drugs in Time for Her” In April, Kofi Annan, the UN Secretary General, said it would take just $7-10 billion a year to mobilize the resources necessary to reverse the ravages not only of HIV, but of tuberculosis…
Pendulum Swing: Treatment Paradigms Come and Go, But the Virus and Its Problematic Potions Appear Intractable
TAGline • 2001Treatment Paradigms Come and Go, But the Virus and Its Problematic Potions Appear Intractable Prairie Fire “Don’t tell me nothin’ about no AIDS because that won’t impact me. And if I was to get it, all I’d have to do is take a pill in the morning and I’ll be OK.” — A 15-year old…
Report and Recommendations from the STI Workshop, October 2000
Publication • 2001January 31, 2001 STRUCTURED TREATMENT INTERRUPTIONS WORKSHOP Workshop Summary The investigation of Structured Treatment Interruption (STI) has fluid borders. Interruption is considered a treatment strategy per se, an adjunct to treatment, as well as the removal of treatment. Though first proposed as an immune-based treatment strategy, STI is now being explored as a research tool…
Vaccine Notes: From the 12th Colloquium of the Cent Gardes, Marnes-la-Coquette, France, 25-27 October
TAGline • 2000From the 12th Colloquium of the Cent Gardes, Marnes-la-Coquette, France, 25-27 October January 2000 Norman Letvin (Harvard Medical School) gets the party pooper prize at this year’s Paris summit: “No one has yet presented compelling evidence that the immune system will be successful by itself in the absence of therapy. It is a seductive idea,…
NIH-Funded AIDS Vaccine Research: A Critical Review
Publication • 2000by Gregg Gonsalves March 2000 From the Introduction The first two decades of AIDS vaccine research have been a series of disappointments and setbacks. Indeed, while at the epidemic’s outset many predicted that it would be easier to develop a vaccine for HIV than effective treatments, the reverse has been the case. Initial approaches to…